↓ Skip to main content

Cochrane Database of Systematic Reviews

Clozapine versus other atypical antipsychotics for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, November 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

blogs
2 blogs
twitter
11 X users
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
211 Dimensions

Readers on

mendeley
442 Mendeley
Title
Clozapine versus other atypical antipsychotics for schizophrenia
Published in
Cochrane database of systematic reviews, November 2010
DOI 10.1002/14651858.cd006633.pub2
Pubmed ID
Authors

Claudia Asenjo Lobos, Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Stefan Leucht

Abstract

Clozapine is an atypical antipsychotic demonstrated to be superior in the treatment of refractory schizophrenia which causes fewer movement disorders. Clozapine, however, entails a significant risk of serious blood disorders such as agranulocytosis which could be potentially fatal. Currently there are a number of newer antipsychotics which have been developed with the purpose to find both a better tolerability profile and a superior effectiveness.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 442 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Chile 1 <1%
Australia 1 <1%
South Africa 1 <1%
Sweden 1 <1%
Spain 1 <1%
United Kingdom 1 <1%
Unknown 434 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 75 17%
Student > Bachelor 59 13%
Researcher 58 13%
Student > Ph. D. Student 43 10%
Student > Postgraduate 30 7%
Other 83 19%
Unknown 94 21%
Readers by discipline Count As %
Medicine and Dentistry 158 36%
Psychology 45 10%
Nursing and Health Professions 26 6%
Pharmacology, Toxicology and Pharmaceutical Science 24 5%
Neuroscience 22 5%
Other 59 13%
Unknown 108 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2022.
All research outputs
#1,513,480
of 25,390,203 outputs
Outputs from Cochrane database of systematic reviews
#3,276
of 12,712 outputs
Outputs of similar age
#5,355
of 109,747 outputs
Outputs of similar age from Cochrane database of systematic reviews
#17
of 86 outputs
Altmetric has tracked 25,390,203 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,712 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 36.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,747 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.